(Q84031639)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543248%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

editorial

0 references

title

Treatment of the ventricular tachycardia with engraftment of pluripotent stem cells-derived cardiomyocytes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543248%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

ventricular tachycardia

1 reference

Jun Fujita

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543248%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Motoaki Sano

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543248%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

13 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543248%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular and Cellular Cardiology

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543248%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543248%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543248%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

3-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543248%20AND%20SRC:MED&resulttype=core&format=json

The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report--2011.

30 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

Four-year follow-up of treatment with intramyocardial skeletal myoblasts injection in patients with ischaemic cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

Embryonic stem cell lines derived from human blastocysts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

Embryonic stem cell trials for macular degeneration: a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

Induced pluripotent stem cell lines derived from human somatic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

Generation of mouse-induced pluripotent stem cells with plasmid vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

Induced pluripotent stem cells--a cautionary note

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

Nongenetic method for purifying stem cell-derived cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

Inducible apoptosis as a safety switch for adoptive cell therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

Growth of engineered human myocardium with mechanical loading and vascular coculture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: a novel in vitro model for the study of conduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

Functional cardiomyocytes derived from human induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

In vivo assessment of the electrophysiological integration and arrhythmogenic risk of myocardial cell transplantation strategies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

Engraftment of human embryonic stem cell derived cardiomyocytes improves conduction in an arrhythmogenic in vitro model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

Human cardiac stem cell differentiation is regulated by a mircrine mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

Mechanical coupling between myofibroblasts and cardiomyocytes slows electric conduction in fibrotic cell monolayers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

Prophylactic catheter ablation for the prevention of defibrillator therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

Patient-specific induced pluripotent stem-cell models for long-QT syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.04.002

10.1016/J.YJMCC.2012.04.002

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543248%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference